Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel-R Hanauske

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Current Drug Metabolism|July 27, 2011
DNA copy number profiles correlate with outcome in colorectal cancer patients treated with fluoropyrimidine/antifolate-based regimensLeticia G Leon, Elisa Giovannetti, Kees Smid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumorsAxel-R Hanauske, Jim Cassidy, Javier Sastre, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2008
Phase-I-study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumoursAxel-R Hanauske, Corinna Endler, Tobias Graefe, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expressionHenry L Gomez, Sergio L Santillana, Carlos S Vallejos, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Current Drug Metabolism|July 27, 2011
DNA copy number profiles correlate with outcome in colorectal cancer patients treated with fluoropyrimidine/antifolate-based regimensLeticia G Leon, Elisa Giovannetti, Kees Smid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumorsAxel-R Hanauske, Jim Cassidy, Javier Sastre, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2008
Phase-I-study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumoursAxel-R Hanauske, Corinna Endler, Tobias Graefe, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expressionHenry L Gomez, Sergio L Santillana, Carlos S Vallejos, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Pageof 2